Cancer-fighting biopharm company logs $191M IPO
May 08, 2015 at 11:04 AM EDT
Adaptimmune Therapeutics, a biopharmaceutical company based in Oxford, England, and Philadelphia, went public this week raising $191 million in an initial public stock offering...
